Skip to main content
Trials logoLink to Trials
. 2016 Sep 26;17:465. doi: 10.1186/s13063-016-1594-8

Erratum to: ‘Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial’

Thomas P Hellyer 1,, Niall H Anderson 2, Jennie Parker 3, Paul Dark 4, Tina Van Den Broeck 5, Suveer Singh 6, Ronan McMullan 7, Ashley M Agus 8, Lydia M Emerson 9, Bronagh Blackwood 9, Savita Gossain 10, Tim S Walsh 11, Gavin D Perkins 12, Andrew Conway Morris 13, Daniel F McAuley 2,8,14, A John Simpson 1
PMCID: PMC5037580  PMID: 27669981

Erratum

Unfortunately, the original version of this article [1] contained an error. There are two references in the text to the threshold for defining VAP as greater than 10^4 colony forming units/ml. These should read greater OR EQUAL to 10^4 colony forming units/ml. The error is in the abstract and in the intervention sections.

In the abstract, please replace:

Patients with clinically suspected VAP undergo BAL and VAP is confirmed by growth of a potential pathogen at [>]104 colony forming units per millilitre (CFU/ml).

With the following correct version:

Patients with clinically suspected VAP undergo BAL and VAP is confirmed by growth of a potential pathogen at [≥]104 colony forming units per millilitre (CFU/ml).

In the Interventions, please replace:

VAP is confirmed by the widely used threshold of growth of a potential pathogen at [>]104 colony forming units per ml (CFU/ml)(13).

With the following correct version:

VAP is confirmed by the widely used threshold of growth of a potential pathogen at [≥]104 colony forming units per ml (CFU/ml)(13).

Footnotes

The online version of the original article can be found under doi:10.1186/s13063-016-1442-x.

Reference

  • 1.Hellyer TP, Anderson NH, Jennie P, Paul D, Tina Van Den B, Suveer S, Ronan MM, Agus AM, Emerson LM, Bronagh B, Savita G, Walsh TS, Perkins GD, Conway Morris A, McAuley DF, Simpson AJ. Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial. Trials. 2016;17:318. doi: 10.1186/s13063-016-1442-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Trials are provided here courtesy of BMC

RESOURCES